UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fouilles de plusieurs occupations du Paléolithique moyen à Mutzig-Rain (Alsace): Premiers résultats

Bulletin de la Société préhistorique française, 2016, Vol.113 (3), p.429-474

2016

Volltextzugriff (PDF)

End-to-end conformational communication through a synthetic purinergic receptor by ligand-induced helicity switching

Nature chemistry, 2013-10, Vol.5 (10), p.853-860

2013

Volltextzugriff (PDF)

Connecting the structure of dark matter haloes to the primordial power spectrum

Monthly notices of the Royal Astronomical Society, 2020-07, Vol.495 (4), p.4994-5013

2020

Volltextzugriff (PDF)

Dibenzazepinyl ureas as dual NMR and CD probes of helical screw-sense preference in conformationally equilibrating dynamic foldamers

Chemical communications (Cambridge, England), 2017, Vol.53 (78), p.10768-10771

2017

Volltextzugriff (PDF)

Erratum: Connecting the structure of dark matter haloes to the primordial power spectrum

Monthly notices of the Royal Astronomical Society, 2020-08, Vol.496 (4), p.4700-4700

2020

Volltextzugriff (PDF)

Length-Dependent Formation of Transmembrane Pores by 310-Helical α‑Aminoisobutyric Acid Foldamers

Journal of the American Chemical Society, 2016-01, Vol.138 (2), p.688-695

2016

Volltextzugriff (PDF)

Designing Foldamer-Foldamer Interactions in Solution: The Roles of Helix Length and Terminus Functionality in Promoting the Self-Association of Aminoisobutyric Acid Oligomers

Chemistry : a European journal, 2014-11, Vol.20 (48), p.15981-15990

2014

Volltextzugriff (PDF)

Dibenzazepinyl ureas as dual NMR and CD probes of helical screw-sense preference in conformationally equilibrating dynamic foldamersElectronic supplementary information (ESI) available: Experimental and spectroscopic data for all new compounds. See DOI: 10.1039/c7cc06427f

2017-09

Volltextzugriff (PDF)

Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission

Journal of antimicrobial chemotherapy, 2015-07, Vol.70 (7), p.2108-2120

2015

Volltextzugriff (PDF)

The Role of Terminal Functionality in the Membrane and Antibacterial Activity of Peptaibol‐Mimetic Aib Foldamers

Chemistry : a European journal, 2018-02, Vol.24 (9), p.2249-2256

2018

Volltextzugriff (PDF)

Flexible Vesiculovasoscopy Using a Microoptical System in a Human Cadaver Model: An Experimental Approach for Atraumatic Endoscopy of the Seminal Tract

Journal of endourology, 2016-08, Vol.30 (8), p.934-938

2016

Volltextzugriff (PDF)

Length-Dependent Formation of Transmembrane Pores by 3 10 -Helical α-Aminoisobutyric Acid Foldamers

Journal of the American Chemical Society, 2016-01, Vol.138 (2), p.688-695

2016

Volltextzugriff (PDF)

Incidence of Tuberculosis among HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy in Europe and North America

Clinical infectious diseases, 2005-12, Vol.41 (12), p.1772-1782

2005

Volltextzugriff (PDF)

Variable Impact on Mortality of AIDS-Defining Events Diagnosed during Combination Antiretroviral Therapy: Not All AIDS-Defining Conditions Are Created Equal

Clinical infectious diseases, 2009-04, Vol.48 (8), p.1138-1151

2009

Volltextzugriff (PDF)

Risk of HIV transmission during combined ART initiation for HIV-infected persons with severe immunosuppression

Journal of antimicrobial chemotherapy, 2017-11, Vol.72 (11), p.3172-3176

2017

Volltextzugriff (PDF)

Efficacy and safety of once-daily ritonavir-boosted atazanavir or darunavir in combination with a dual nucleos(t)ide analogue backbone in HIV-1-infected combined ART (cART)-naive patients with severe immunosuppression: a 48 week, non-comparative, randomized, multicentre trial (IMEA 040 DATA trial)

Journal of antimicrobial chemotherapy, 2016-08, Vol.71 (8), p.2252-2261

2016

Volltextzugriff (PDF)

Decreased darunavir concentrations during once-daily co-administration with maraviroc and raltegravir: OPTIPRIM-ANRS 147 trial

Journal of antimicrobial chemotherapy, 2018-04, Vol.73 (4), p.1020-1024

2018

Volltextzugriff (PDF)

Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial

Journal of antimicrobial chemotherapy, 2016-03, Vol.71 (3), p.783-793

2016

Volltextzugriff (PDF)

Flexible Vesiculo-Vasoscopy Using a Micro-Optical System in a Human Cadaver Model: An Experimental Approach for Atraumatic Endoscopy of the Seminal Tract

Videourology (New Rochelle, N.Y.), 2016-10, Vol.30 (5), Article vid.2016.0034

2016

Volltextzugriff (PDF)

Treatment for tuberculosis-associated immune reconstitution inflammatory syndrome in 34 HIV-infected patients

The international journal of tuberculosis and lung disease, 2012-10, Vol.16 (10), p.1365-1370

2012

Volltextzugriff (PDF)

Requirements on Real-Time-Capable Automotive Ethernet Architectures

SAE International journal of passenger cars. Electronic and electrical systems, 2014-04, Vol.7 (2), p.384-393, Article 2014-01-0245

2014

Volltextzugriff (PDF)

Importance of baseline prognostic factors with increasing time since initiation of highly active antiretroviral therapy: collaborative analysis of cohorts of HIV-1-infected patients

Journal of acquired immune deficiency syndromes (1999), 2007-12, Vol.46 (5), p.607-615

Antiretroviral Therapy Cohort Collaboration

2007

Volltextzugriff (PDF)

Mastering MPSoCs for Mixed-critical Applications

IPSJ Transactions on System LSI Design Methodology, 2011, Vol.4, pp.91-116

2011

Volltextzugriff (PDF)

Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavir

Journal of antimicrobial chemotherapy, 2011-08, Vol.66 (8), p.1869-1877

2011

Volltextzugriff (PDF)

Maintaining Antiretroviral Therapy Reduces the Risk of AIDS-Defining Events in Patients with Uncontrolled Viral Replication and Profound Immunodeficiency

Clinical infectious diseases, 2008-01, Vol.46 (2), p.296-304

2008

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(26)

Publikationsform

Sprache

Englisch
(34)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(21)
Humans
(17)
Adult
(16)
Infectious Diseases
(16)
Male
(16)
Female
(15)
Life Sciences & Biomedicine
(15)
Hiv Infections - Drug Therapy
(13)
Middle Aged
(11)
Microbiology
(10)
Viral Load
(10)
Biological And Medical Sciences
(9)
Hiv
(9)
Human Immunodeficiency Virus
(9)
Medical Sciences
(9)
Pharmacology & Pharmacy
(8)
Virology
(8)
Anti-Hiv Agents - Therapeutic Use
(7)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(7)
Antiretroviral Drugs
(7)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

11 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Fouilles de plusieurs occupations du Paléolithique moyen à Mutzig-Rain (Alsace): Premiers résultats

End-to-end conformational communication through a synthetic purinergic receptor by ligand-induced helicity switching

Connecting the structure of dark matter haloes to the primordial power spectrum

Dibenzazepinyl ureas as dual NMR and CD probes of helical screw-sense preference in conformationally equilibrating dynamic foldamers

Erratum: Connecting the structure of dark matter haloes to the primordial power spectrum

Length-Dependent Formation of Transmembrane Pores by 310-Helical α‑Aminoisobutyric Acid Foldamers

Designing Foldamer-Foldamer Interactions in Solution: The Roles of Helix Length and Terminus Functionality in Promoting the Self-Association of Aminoisobutyric Acid Oligomers

Dibenzazepinyl ureas as dual NMR and CD probes of helical screw-sense preference in conformationally equilibrating dynamic foldamersElectronic supplementary information (ESI) available: Experimental and spectroscopic data for all new compounds. See DOI: 10.1039/c7cc06427f

Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission

The Role of Terminal Functionality in the Membrane and Antibacterial Activity of Peptaibol‐Mimetic Aib Foldamers

Flexible Vesiculovasoscopy Using a Microoptical System in a Human Cadaver Model: An Experimental Approach for Atraumatic Endoscopy of the Seminal Tract

Length-Dependent Formation of Transmembrane Pores by 3 10 -Helical α-Aminoisobutyric Acid Foldamers

Incidence of Tuberculosis among HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy in Europe and North America

Variable Impact on Mortality of AIDS-Defining Events Diagnosed during Combination Antiretroviral Therapy: Not All AIDS-Defining Conditions Are Created Equal

Risk of HIV transmission during combined ART initiation for HIV-infected persons with severe immunosuppression

Efficacy and safety of once-daily ritonavir-boosted atazanavir or darunavir in combination with a dual nucleos(t)ide analogue backbone in HIV-1-infected combined ART (cART)-naive patients with severe immunosuppression: a 48 week, non-comparative, randomized, multicentre trial (IMEA 040 DATA trial)

Decreased darunavir concentrations during once-daily co-administration with maraviroc and raltegravir: OPTIPRIM-ANRS 147 trial

Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial

Flexible Vesiculo-Vasoscopy Using a Micro-Optical System in a Human Cadaver Model: An Experimental Approach for Atraumatic Endoscopy of the Seminal Tract

Treatment for tuberculosis-associated immune reconstitution inflammatory syndrome in 34 HIV-infected patients

Requirements on Real-Time-Capable Automotive Ethernet Architectures

Importance of baseline prognostic factors with increasing time since initiation of highly active antiretroviral therapy: collaborative analysis of cohorts of HIV-1-infected patients

Mastering MPSoCs for Mixed-critical Applications

Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavir

Maintaining Antiretroviral Therapy Reduces the Risk of AIDS-Defining Events in Patients with Uncontrolled Viral Replication and Profound Immunodeficiency

Suchergebnisse filtern